Related Experiment Video
Updated: Sep 12, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Brief Report: Switching to Long-Acting CAB/RPV: Data From an Italian Monocentric Cohort
Maddalena Matone1, Marco Piscaglia1,2, Andrea Giacomelli3
1Department of Infectious Diseases, Unit I, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Background:
Cabotegravir (CAB)/rilpivirine (RPV) is the first long-acting injectable (LAI) antiretroviral therapy approved for virologically suppressed adults with HIV-1.
Setting:
Italian single centre cohort.
Methods:
We conducted a retrospective observational study to assess the durability, adherence to the prescribed injection schedule, and reasons for discontinuation of CAB/RPV LAI administered every 8 weeks (Q8W).
Results:
One hundred thirty-eight patients were included with a median observation period of 43 weeks [interquartile range (IQR) 34-47 weeks]. Of these, 32 (23.2%) were female, and the median age was 51 years (IQR 40-58 years). Twelve patients (8.7%) discontinued CAB/RPV LAI treatment with a median time to discontinuation of 21 weeks (IQR 12-35 weeks), and 92.8% of the injections occurred within the CAB/RPV LAI schedule. The most common reason for discontinuation was injection-related pain (5/12). No confirmed virological failure occurred during the period of observation with 3 individuals who experienced virological blips.
Conclusions:
Our findings showed that CAB/RPV LAI Q8W is tolerated well in clinical practice, with high adherence to the injection schedule and few discontinuations mainly related to injection site-related pain.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Longitudinal Studies
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Retroviruses
Analysis of Population Pharmacokinetic Data

